% | $
Quotes you view appear here for quick access.

Ohr Pharmaceutical, Inc. Message Board

  • gs88gs88 gs88gs88 Dec 11, 2013 6:02 AM Flag

    International Cachexia Conference

    CEO presented yesterday at the International Cachexia Conference in Japan re: the previously released phase 2 study with our cachexia drug. Although no new information was released, this was a great audience to get the story out. As a physician, seeing 11 of 18 patients with cancer cachexia wanting to stay on the drug for quality of life, is meaningful. This drug will likely provide an unmet need for many patients.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.78+0.05(+1.83%)Aug 29 4:00 PMEDT